George Washko, MD, discusses a late-breaking OBERON/TITANIA analysis showing tozorakimab reduces segmental mucus plug scores in COPD.
George Washko, MD
Advertisement
Associate Professor of Medicine, Harvard Medical School
Associate Physician, Brigham and Women's Hospital
Articles by George Washko, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Tezepelumab Meets Co-Primary End Points in Phase 3 CROSSING Trial in EoE
2
Reaching Comprehensive Disease Control in UC, With Stefan Schreiber, MD
3
Mirikizumab Deep Remission in Crohn’s Disease, With Stefan Schreiber, MD
4
Revita Reduces Weight Regain After GLP-1 Discontinuation in REMAIN-1
5